Discovery of farnesoid X receptor and its role in bile acid metabolism

JYL Chiang, JM Ferrell - Molecular and cellular endocrinology, 2022 - Elsevier
In 1995, the nuclear hormone orphan receptor farnesoid X receptor (FXR, NR1H4) was
identified as a farnesol receptor expressed mainly in liver, kidney, and adrenal gland of rats …

Bile acid signaling in metabolic disease and drug therapy

T Li, JYL Chiang, Q Ma - Pharmacological reviews, 2014 - Elsevier
Bile acids are the end products of cholesterol catabolism. Hepatic bile acid synthesis
accounts for a major fraction of daily cholesterol turnover in humans. Biliary secretion of bile …

[HTML][HTML] Bile acid metabolism and signaling

JYL Chiang - Comprehensive physiology, 2013 - ncbi.nlm.nih.gov
Bile acids are important physiological agents for intestinal nutrient absorption and biliary
secretion of lipids, toxic metabolites, and xenobiotics. Bile acids also are signaling …

Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases

F Engin, GS Hotamisligil - Diabetes, obesity and metabolism, 2010 - Wiley Online Library
The endoplasmic reticulum (ER) is a eukaryotic organelle that plays important roles in
protein synthesis, folding and trafficking, calcium homoeostasis and lipid and steroid …

Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode

MA Kotb - International journal of molecular sciences, 2012 - mdpi.com
Ursodeoxycholic acid (UDCA) is a steroid bile acid approved for primary biliary cirrhosis
(PBC). UDCA is reported to have “hepato-protective properties”. Yet, UDCA has …

Bile acid signaling in metabolic and inflammatory diseases and drug development

T Li, JYL Chiang, G Guo - Pharmacological Reviews, 2024 - Elsevier
Bile acids are the end products of cholesterol catabolism. Hepatic bile acid synthesis
accounts for a major fraction of daily cholesterol turnover in humans. Biliary secretion of bile …

Hepatic fibrosis in dogs

VM Eulenberg, JA Lidbury - Journal of Veterinary Internal …, 2018 - Wiley Online Library
Hepatic fibrosis is commonly diagnosed in dogs, often as a sequela to chronic hepatitis
(CH). The development of fibrosis is a crucial event in the progression of hepatic disease …

Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells

F Arenas, I Hervias, M Úriz, R Joplin… - The Journal of …, 2008 - Am Soc Clin Investig
Primary biliary cirrhosis (PBC) is a cholestatic disease associated with autoimmune
phenomena and alterations in both biliary bicarbonate excretion and expression of the …

Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases?

SJ Keely, CJ Steer… - American Journal of …, 2019 - journals.physiology.org
The secondary bile acid ursodeoxycholic acid (UDCA) has long been known to have
medicinal properties. As the therapeutically active component of bear bile, it has been used …

Abnormal enterohepatic circulation of bile acids caused by fructooligosaccharide supplementation along with a high-fat diet

F Zeng, S He, Y Sun, X Li, K Chen, H Wang, S Man… - Food & Function, 2024 - pubs.rsc.org
Fructooligosaccharide (FOS) is a widely used prebiotic and health food ingredient, but few
reports have focused on its risk to specific populations. Recently, it has been shown that the …